Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.33 |
| ▸ | TET3 | O43151 | 1/20 | 0.33 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16703910 | 0.80 | — | — | |
| SCHEMBL38691 | 0.80 | — | — | |
| SCHEMBL23581465 | 0.74 | TSHR (0.38) | SLC6A2SLC6A4BLMSLC6A3MEN1 | |
| SCHEMBL1135900 | 0.72 | LMNA (0.32) | LMNATET2TET3TET1ALOX15 | |
| SCHEMBL1948588 | 0.72 | — | — | |
| SCHEMBL17137797 | 0.72 | — | — | |
| SCHEMBL11879827 | 0.72 | — | — | |
| SCHEMBL5872870 | 0.72 | — | — | |
| SCHEMBL471880 | 0.72 | — | — | |
| SCHEMBL18277280 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3823592-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | The Hong Kong University Of Science And Technology (CN) | 2021-05-26 | — | — | EP | claimed |
| CN-112702992-A | Compositions and methods for controlled release of target agents | 香港科技大学 | 2021-04-23 | — | — | CN | claimed |
| WO-2020015737-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2020-01-23 | — | — | WO | claimed |
| JP-4721702-B2 | — | — | 2011-07-13 | — | — | JP | claimed |
| EP-1515784-A1 | SEPARATION SYSTEM, COMPONENTS OF A SEPARATION SYSTEM AND METHODS OF MAKING AND USING THEM | Teledyne Isco, Inc. (US) | 2005-03-23 | — | — | EP | claimed |
| WO-2004002603-A1 | SEPARATION SYSTEM, COMPONENTS OF A SEPARATION SYSTEM AND METHODS OF MAKING AND USING THEM | ISCO, INC. (US) | 2004-01-08 | — | — | WO | claimed |
| US-20230093832-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2023-03-30 | — | — | US | disclosed |
| US-11571283-B2 | Bonding of soft gingival tissues with dental prostheses | ESTHETIC IMPLANT SOLUTIONS, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| US-20230012924-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2023-01-19 | — | — | US | disclosed |
| CN-115135303-A | Compositions and methods for controlled release of target agents | 香港科技大学 | 2022-09-30 | — | — | CN | disclosed |
| WO-2021143736-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2021-07-22 | — | — | WO | disclosed |
| US-20210220266-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (HK) | 2021-07-22 | — | — | US | disclosed |
| WO-2021126780-A1 | COMBINATION OF CROSSLINKERS TO IMPROVE COATING PROPERTIES | BASF SE (DE) | 2021-06-24 | — | — | WO | disclosed |
| US-7498394-B2 | (Meth)acrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2009-03-03 | — | — | US | disclosed |
| CN-100392182-C | Printing coated paper | JUJO PAPER CO LTD (JP) | 2008-06-04 | — | — | CN | disclosed |
| CN-101125303-A | Non-agglomerating ion exchange mixed beds | LANXESS DEUTSCHLAND GMBH (DE) | 2008-02-20 | — | — | CN | disclosed |
| US-20080009555-A1 | Non-agglomerating mixed bed ion exchangers | LANXESS DEUTSCHLAND GMBH | 2008-01-10 | — | — | US | disclosed |
| EP-1875965-A2 | Non-agglomerating ion exchange mixed beds | LANXESS Deutschland GmbH (DE) | 2008-01-09 | — | — | EP | disclosed |
| US-20060252900-A1 | (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained | REGENTS OF THE UNIVERSITY OF COLORADO, THE | 2006-11-09 | — | — | US | disclosed |
| CN-1441870-A | Printing coated paper | JUJO PAPER CO LTD (JP) | 2003-09-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230093832-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | CDC37, HSP90B1, CRYAA | LMNA 2171/4885TET2 4882/4885TET3 4775/4885 |
| US-20210220266-A1 | COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT | IAPP, SCTR, GRPR | LMNA 1707/4885TET2 4881/4885TET3 4849/4885 |
| US-20060252900-A1 | (Meth)arcrylic and (meth)acrylamide monomers, polymerizable compositions, and polymers obtained | MMAB, MAT1A, MAT2A | LMNA 4478/4885TET2 24/4885TET3 20/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.